$TRXDW

2018 Q3 Form 10-Q Financial Statement

#000156459018028653 Filed on November 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $5.422M $183.0K
YoY Change 2862.84% -87.52%
Cost Of Revenue $4.249M $921.0K
YoY Change 361.35% -10.67%
Gross Profit $1.173M -$738.0K
YoY Change -258.94% -269.66%
Gross Profit Margin 21.63% -403.28%
Selling, General & Admin $9.505M $7.448M
YoY Change 27.62% 38.77%
% of Gross Profit 810.32%
Research & Development $4.838M $4.889M
YoY Change -1.04% -30.27%
% of Gross Profit 412.45%
Depreciation & Amortization $3.270M $678.0K
YoY Change 382.3% 52.02%
% of Gross Profit 278.77%
Operating Expenses $14.34M $12.34M
YoY Change 16.26% -0.33%
Operating Profit -$11.88M -$15.67M
YoY Change -24.18% 15.62%
Interest Expense $685.0K $563.0K
YoY Change 21.67% 30.32%
% of Operating Profit
Other Income/Expense, Net -$9.106M -$23.58M
YoY Change -61.39% 5004.33%
Pretax Income -$20.99M -$39.25M
YoY Change -46.53% 180.08%
Income Tax -$781.0K -$738.0K
% Of Pretax Income
Net Earnings -$20.21M -$38.51M
YoY Change -47.53% 197.54%
Net Earnings / Revenue -372.67% -21045.36%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.10 -$3.35
COMMON SHARES
Basic Shares Outstanding 209.1M shares
Diluted Shares Outstanding 209.1M shares

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.40M $24.50M
YoY Change 232.24% -42.35%
Cash & Equivalents $41.75M $24.48M
Short-Term Investments $39.70M
Other Short-Term Assets $9.039M $8.245M
YoY Change 9.63% 1.18%
Inventory $10.24M $11.27M
Prepaid Expenses $2.540M $1.379M
Receivables $5.669M $253.0K
Other Receivables $93.00K $139.0K
Total Short-Term Assets $106.4M $44.27M
YoY Change 140.37% -17.32%
LONG-TERM ASSETS
Property, Plant & Equipment $6.659M $7.197M
YoY Change -7.48% 55.98%
Goodwill $70.67M $71.04M
YoY Change -0.52% 1.56%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $224.0K $279.0K
YoY Change -19.71% 342.86%
Total Long-Term Assets $121.1M $139.5M
YoY Change -13.13% -2.81%
TOTAL ASSETS
Total Short-Term Assets $106.4M $44.27M
Total Long-Term Assets $121.1M $139.5M
Total Assets $227.6M $183.7M
YoY Change 23.86% -6.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.785M $2.625M
YoY Change 6.1% 1.12%
Accrued Expenses $7.432M $8.926M
YoY Change -16.74% 23.19%
Deferred Revenue $1.270M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $12.04M $18.51M
YoY Change -34.94% -36.16%
LONG-TERM LIABILITIES
Long-Term Debt $19.10M $12.80M
YoY Change 49.22% 80.28%
Other Long-Term Liabilities $26.70M $42.60M
YoY Change -37.32% 206.47%
Total Long-Term Liabilities $45.80M $55.40M
YoY Change -17.33% 163.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.04M $18.51M
Total Long-Term Liabilities $45.80M $55.40M
Total Liabilities $63.50M $83.16M
YoY Change -23.65% 34.35%
SHAREHOLDERS EQUITY
Retained Earnings -$503.0M -$371.5M
YoY Change 35.39% 28.61%
Common Stock $664.7M $468.3M
YoY Change 41.93% 10.15%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.000K
YoY Change -99.01%
Treasury Stock Shares $2.136K
Shareholders Equity $164.1M $100.6M
YoY Change
Total Liabilities & Shareholders Equity $227.6M $183.7M
YoY Change 23.86% -6.75%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$20.21M -$38.51M
YoY Change -47.53% 197.54%
Depreciation, Depletion And Amortization $3.270M $678.0K
YoY Change 382.3% 52.02%
Cash From Operating Activities -$16.45M -$12.03M
YoY Change 36.74% 23.64%
INVESTING ACTIVITIES
Capital Expenditures $130.0K $110.0K
YoY Change 18.18% -69.44%
Acquisitions
YoY Change
Other Investing Activities -$39.62M
YoY Change
Cash From Investing Activities -$39.75M -$110.0K
YoY Change 36036.36% -69.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 150.0K 7.170M
YoY Change -97.91% -479.37%
NET CHANGE
Cash From Operating Activities -16.45M -12.03M
Cash From Investing Activities -39.75M -110.0K
Cash From Financing Activities 150.0K 7.170M
Net Change In Cash -56.05M -4.970M
YoY Change 1027.77% -58.51%
FREE CASH FLOW
Cash From Operating Activities -$16.45M -$12.03M
Capital Expenditures $130.0K $110.0K
Free Cash Flow -$16.58M -$12.14M
YoY Change 36.57% 20.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16578000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3713000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10536000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3227000
us-gaap Gross Profit
GrossProfit
6042000
us-gaap Gross Profit
GrossProfit
486000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15384000
trxc Issuance Costs For Warrants
IssuanceCostsForWarrants
627000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2920000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4889000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5819000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4249000
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4528000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
921000
CY2018Q3 us-gaap Gross Profit
GrossProfit
1173000
CY2017Q3 us-gaap Gross Profit
GrossProfit
-738000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4838000
CY2018Q3 trxc Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
1358000
CY2017Q3 trxc Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-773000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16814000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11881000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17835000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12000000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3686000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9989000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8688000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2674000
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1821000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8244000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5144000
trxc Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-81000
trxc Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-1226000
CY2018Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
345000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
345000
CY2018Q3 trxc Gain Loss On Sale Of Developed System Assets Net
GainLossOnSaleOfDevelopedSystemAssetsNet
-44000
trxc Gain Loss On Sale Of Developed System Assets Net
GainLossOnSaleOfDevelopedSystemAssetsNet
11915000
CY2018Q3 trxc Reversal Of Transfer Fee Accrual
ReversalOfTransferFeeAccrual
2994000
trxc Reversal Of Transfer Fee Accrual
ReversalOfTransferFeeAccrual
2994000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
13054000
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
14931000
us-gaap Costs And Expenses
CostsAndExpenses
36969000
us-gaap Costs And Expenses
CostsAndExpenses
44499000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15669000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30927000
us-gaap Operating Income Loss
OperatingIncomeLoss
-44013000
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
8760000
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
22887000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
24438000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25213000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
391000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
62000
us-gaap Investment Income Interest
InvestmentIncomeInterest
982000
us-gaap Investment Income Interest
InvestmentIncomeInterest
124000
CY2018Q3 us-gaap Interest Expense
InterestExpense
685000
CY2017Q3 us-gaap Interest Expense
InterestExpense
563000
us-gaap Interest Expense
InterestExpense
3398000
us-gaap Interest Expense
InterestExpense
1581000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-194000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-109000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-294000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9106000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23582000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26963000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26964000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20987000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39251000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57890000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70977000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-781000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-738000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2554000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2337000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-20206000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-38513000
us-gaap Net Income Loss
NetIncomeLoss
-55336000
us-gaap Net Income Loss
NetIncomeLoss
-68640000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-561000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2952000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2651000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9515000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20767000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35561000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57987000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59125000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
209088000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149516000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
204531000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
134622000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41748000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91217000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6670000
CY2018Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
39670000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5669000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1536000
CY2018Q3 us-gaap Inventory Net
InventoryNet
10242000
CY2017Q4 us-gaap Inventory Net
InventoryNet
10817000
CY2018Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
51000
CY2017Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
80000
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
9039000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9344000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
106419000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
112994000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
663000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6389000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6659000
CY2018Q3 us-gaap Goodwill
Goodwill
70669000
CY2017Q4 us-gaap Goodwill
Goodwill
71368000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
224000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
192000
CY2018Q3 us-gaap Assets
Assets
227559000
CY2017Q4 us-gaap Assets
Assets
250251000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2785000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3771000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7432000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10974000
CY2018Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1270000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1088000
CY2017Q4 trxc Deferred Gain From Sale Of Property Current
DeferredGainFromSaleOfPropertyCurrent
7500000
CY2018Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
555000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
719000
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4788000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12042000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28840000
CY2018Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
131000
CY2018Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11549000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11699000
CY2018Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
19106000
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
8385000
CY2018Q3 trxc Warrant Liability
WarrantLiability
15044000
CY2017Q4 trxc Warrant Liability
WarrantLiability
14090000
CY2018Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5624000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
8389000
CY2018Q3 us-gaap Liabilities
Liabilities
63496000
CY2017Q4 us-gaap Liabilities
Liabilities
71403000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
212000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
199000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
664439000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
621261000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-502965000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447640000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2377000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5028000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
164063000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
227559000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250251000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
212631801
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
199282003
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
212631801
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
199282003
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6694000
trxc Issuance Of Common Stock And Warrants Net Of Issuance Costs
IssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
279000
trxc Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
34880000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1664000
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
1000
trxc Stock Issued During Period Value Sale Of Assets
StockIssuedDuringPeriodValueSaleOfAssets
3000000
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
11000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2651000
us-gaap Profit Loss
ProfitLoss
-55336000
us-gaap Profit Loss
ProfitLoss
-68640000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1876000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1816000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
575000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
212000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
51000
us-gaap Share Based Compensation
ShareBasedCompensation
6694000
us-gaap Share Based Compensation
ShareBasedCompensation
5321000
trxc Non Employee Warrant Awards
NonEmployeeWarrantAwards
571000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2572000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2320000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1400000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-308000
trxc Recovery Of Transfer Fee
RecoveryOfTransferFee
2994000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4262000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-886000
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-28000
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-79000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1276000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2454000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3519000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-903000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1599000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-56000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
207000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
361000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35641000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37549000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39619000
trxc Proceeds From Sale Of Developed System Assets Net
ProceedsFromSaleOfDevelopedSystemAssetsNet
4496000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
490000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1488000
trxc Payments To Acquire Intellectual Property
PaymentsToAcquireIntellectualProperty
418000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
32000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35581000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1906000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15305000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
13343000
trxc Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts
18828000
trxc Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts
12956000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
395000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
395000
trxc Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
279000
trxc Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
31546000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1662000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
168000
trxc Proceeds From Issuance Of Common Stock For Sale Of Property
ProceedsFromIssuanceOfCommonStockForSaleOfProperty
3000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11396000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5449000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16141000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36045000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-114000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-311000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-55195000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3721000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97606000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34590000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42411000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30869000
us-gaap Interest Paid Net
InterestPaidNet
1135000
us-gaap Interest Paid Net
InterestPaidNet
597000
trxc Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
2160000
trxc Transfer Of Property And Equipment To Inventories
TransferOfPropertyAndEquipmentToInventories
648000
trxc Conversion Of Contingent Consideration To Common Stock
ConversionOfContingentConsiderationToCommonStock
5227000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
300000
trxc Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital
ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital
23485000
trxc Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital
ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital
2289000
trxc Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
4272000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include identifiable intangible assets and goodwill, contingent consideration, warrant liabilities, stock compensation expense, revenue recognition, restructuring and other charges, excess and obsolete inventory reserves, and deferred tax asset valuation allowances.</p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentrations and Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents, including amounts held in money market accounts. The Company places cash deposits with a federally insured financial institution. The Company maintains its cash at banks and financial institutions it considers to be of high credit quality; however, the Company&#8217;s cash deposits may at times exceed the FDIC insured limit. Balances in excess of federally insured limitations may not be insured. The Company has not experienced losses on these accounts, and management believes that the Company is not exposed to significant risks on such accounts.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s accounts receivable are derived from net revenue to customers located throughout the world. The Company evaluates its customers&#8217; financial condition and, generally, requires no collateral from its customers. The Company provides reserves for potential credit losses but has not experienced significant losses to date. The Company had four customers who accounted for 88% of the Company&#8217;s net accounts receivable at September 30, 2018 and one customer who constituted 88% of the Company&#8217;s net accounts receivable at December 31, 2017. <font style="Background-color:#FFFFFF;color:#222222;">The Company had five customers who accounted for 68% of the Company&#8217;s net revenue for the nine months ended September 30, 2018 and two customers who constituted 89% of the Company&#8217;s net revenue for the nine months ended September 30, 2017. The Company had four customers who accounted for 96% of the Company&#8217;s net revenue for the three months ended September 30, 2018 and five customers who constituted 100% of the Company&#8217;s net revenue for the three months ended September 30, 2017.</font></p></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Classification of Certain Items Within the Company&#8217;s Form 10-K</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications of prior period amounts will be made within the Company&#8217;s Form 10-K filing for the year ended December 31, 2018 to conform to current period presentation. Specifically, during the nine months ended September 30, 2018, the Company determined that the amount related to the deferred gain on sale of SurgiBot assets as reflected within one line in the operating activities section of the consolidated statement of cash flows for the year ended December 31, 2017 should have been classified as cash flows provided from investing activities.&nbsp;&nbsp;There is no impact to the consolidated statements of operations or consolidated balance sheets. The Company evaluated the effect of this misclassification and concluded it was not material to any of its previously issued consolidated financial statements.&#160;Upon revision, cash flows from operating activities for the year ended December 31, 2017, will decrease by $7.5 million to cash and cash equivalents used in operating activities of $47.3 million and cash flows from investing activities will increase by $7.5 million to cash and cash equivalents provided by investing activities of $5.5 million.&nbsp;&nbsp;There is no impact of the reclassification to the nine months ended September 30, 2017.</p></div>
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2017 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2017Q4 trxc Deferred Gain On Sale Of Property Current
DeferredGainOnSaleOfPropertyCurrent
7500000
trxc Period Of Service Sale Arrangement
PeriodOfServiceSaleArrangement
P5Y
trxc Period Of Service Sale Arrangement At Stated Service Price
PeriodOfServiceSaleArrangementAtStatedServicePrice
P4Y
trxc Product Warranty Period
ProductWarrantyPeriod
P1Y
CY2018Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4400000
CY2018Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
100000
CY2017Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
CY2018Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
40940000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 trxc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Decrease In Deferred Tax Assets Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDecreaseInDeferredTaxAssetsIncomeTaxExpense
36100000
CY2017 trxc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Decrease In Valuation Allowance Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDecreaseInValuationAllowanceIncomeTaxExpense
36100000
trxc Tax Cuts And Jobs Act Of2017 Measurement Period
TaxCutsAndJobsActOf2017MeasurementPeriod
P1Y
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47300000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5500000
CY2018Q3 us-gaap Cash
Cash
6987000
CY2017Q4 us-gaap Cash
Cash
4039000
CY2018Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
34761000
CY2017Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
87178000
CY2018Q3 trxc Fair Value Assets Transfers Between Level1 Level2 And Level3 Amount
FairValueAssetsTransfersBetweenLevel1Level2AndLevel3Amount
0
CY2017Q4 trxc Fair Value Assets Transfers Between Level1 Level2 And Level3 Amount
FairValueAssetsTransfersBetweenLevel1Level2AndLevel3Amount
0
CY2018Q3 trxc Fair Value Liabilities Transfers Between Level1 Level2 And Level3 Amount
FairValueLiabilitiesTransfersBetweenLevel1Level2AndLevel3Amount
0
CY2017Q4 trxc Fair Value Liabilities Transfers Between Level1 Level2 And Level3 Amount
FairValueLiabilitiesTransfersBetweenLevel1Level2AndLevel3Amount
0
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
663000
CY2018Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
42411000
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
12104000
CY2018Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
27148000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1422000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17256000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
504000
CY2017Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1609000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
73000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
73000
CY2018Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
5669000
CY2017Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1536000
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4212000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4432000
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6030000
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6385000
CY2018Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
437000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
595000
CY2018Q3 trxc Advance To Vendors
AdvanceToVendors
6406000
CY2017Q4 trxc Advance To Vendors
AdvanceToVendors
6403000
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2540000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1519000
CY2018Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
93000
CY2018Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
400000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6389000
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
97606000
CY2017 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
12418000
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
26508000
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
24900000
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2018Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
5742000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15888000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10597000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9218000
us-gaap Depreciation
Depreciation
1876000
us-gaap Depreciation
Depreciation
1816000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-699000
CY2018Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
61800000
CY2017Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
61800000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
trxc Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.050
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.044
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.033
CY2018Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2018Q3 trxc Tax Cuts And Jobs Act Of2017 Accounting Complete
TaxCutsAndJobsActOf2017AccountingComplete
false
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4975000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4533000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
814000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
386000
CY2018Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
299000
CY2017Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1414000
CY2018Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
190000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3192000
CY2018Q3 us-gaap Interest Payable Current
InterestPayableCurrent
159000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
309000
CY2018Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
158000
CY2017Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
41000
trxc Service Agreement Termination Description
ServiceAgreementTerminationDescription
In February 2018, the Company terminated its relationship with a vendor who had been issued warrants to acquire 950,000 shares of Common Stock (the “Service Warrants”) with staggered vesting requirements. As part of the termination agreement, the Company accelerated the full vesting of the Service Warrants.
CY2014Q3 trxc Warrant Expiration Period
WarrantExpirationPeriod
P7Y
CY2017Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
24900000
CY2017Q2 trxc Proceeds From Issuance Of Equity Net
ProceedsFromIssuanceOfEquityNet
23200000
CY2017Q2 trxc Warrants Exercised During Period
WarrantsExercisedDuringPeriod
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
0
CY2017Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
0

Files In Submission

Name View Source Status
0001564590-18-028653-index-headers.html Edgar Link pending
0001564590-18-028653-index.html Edgar Link pending
0001564590-18-028653.txt Edgar Link pending
0001564590-18-028653-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trxc-10q_20180930.htm Edgar Link pending
trxc-20180930.xml Edgar Link completed
trxc-20180930.xsd Edgar Link pending
trxc-20180930_cal.xml Edgar Link unprocessable
trxc-20180930_def.xml Edgar Link unprocessable
trxc-20180930_lab.xml Edgar Link unprocessable
trxc-20180930_pre.xml Edgar Link unprocessable
trxc-ex311_6.htm Edgar Link pending
trxc-ex312_10.htm Edgar Link pending
trxc-ex321_9.htm Edgar Link pending
trxc-ex322_8.htm Edgar Link pending